Executive leadership at Tharimmune.
Board of directors at Tharimmune.
Research analysts covering Tharimmune.
Recent press releases and 8-K filings for THAR.
Tharimmune Shareholders Approve Director Elections, Warrant Issuances, and Equity Plan Amendment
THAR
Board Change
Proxy Vote Outcomes
Executive Compensation
- Tharimmune shareholders approved the election of two new directors, Jill E. Summers and William Wiley, to the company's board.
- Shareholders approved the issuance of common stock upon the exercise of Strategic Advisor Warrants and Cryptocurrency Pre-Funded Warrants, the latter stemming from a November 3rd, 2025 private placement offering.
- The issuance of restricted stock units to Clear Street, LLC and shares of common stock upon their settlement, also connected to the November 3rd, 2025 private placement offering, received shareholder approval.
- An amendment to the 2023 Omnibus Equity Incentive Plan was approved, increasing the number of shares available for issuance by 7 million shares.
5 hours ago
Tharimmune Shareholders Approve Key Proposals at Special Meeting
THAR
Board Change
Executive Compensation
Proxy Vote Outcomes
- Tharimmune, Inc. held a special meeting of shareholders on January 30, 2026, to vote on several proposals.
- Shareholders approved the election of two directors, Jill E. Summers and William Wiley.
- The issuance of shares upon the exercise of Strategic Advisor Warrants and Cryptocurrency Pre-Funded Warrants, along with the issuance of restricted stock units to Clear Street, LLC, were all approved.
- An amendment to the 2023 Omnibus Equity Incentive Plan to increase the number of shares available for issuance by 7 million shares was also approved.
- All proposals (1 through 5) were approved based on preliminary vote totals, leading to the conclusion of the meeting without adjournment.
5 hours ago
Tharimmune Shareholders Approve Key Proposals at Special Meeting
THAR
Board Change
Proxy Vote Outcomes
Executive Compensation
- Tharimmune, Inc. shareholders approved all five proposals presented at a special meeting held on January 30, 2026.
- The approved proposals include the election of Jill E. Summers and William Wiley as directors.
- Shareholders also approved the issuance of shares related to Strategic Advisor Warrants and Cryptocurrency Pre-Funded Warrants from a November 3, 2025, private placement offering.
- An amendment to the 2023 Omnibus Equity Incentive Plan was approved, increasing the shares available for issuance by 7 million.
- The issuance of restricted stock units to Clear Street, LLC, and shares upon settlement, connected to the November 3, 2025, private placement, also received shareholder approval.
6 hours ago
Tharimmune Announces Expanded Role as Super Validator on Canton Network
THAR
New Projects/Investments
- Tharimmune, Inc. (NASDAQ: THAR) announced its approval to operate as a Super Validator on the Canton Network, a role that will enable it to secure transactions and accrue rewards in Canton Coin (CC) to bolster its digital asset treasury.
- This expanded role involves contributing to a network responsible for over 700,000 daily transactions totaling $9 trillion in monthly transaction volume.
- Tharimmune is noted as the first publicly traded company to leverage Canton Coin and the first and only publicly traded company supported by the Canton Foundation.
4 days ago
Tharimmune Announces Super Validator Role on Canton Network
THAR
New Projects/Investments
- Tharimmune, Inc. (NASDAQ: THAR) has been approved to operate as a Super Validator on the Canton Network, allowing it to secure transactions and accrue rewards in Canton Coin (CC) to bolster its digital asset treasury.
- As a Super Validator, Tharimmune will provide quarterly research on onchain analytics, community development, governance, and tokenomics, and will host publicly available webinars.
- This role is significant as Super Validators are responsible for over 700,000 daily transactions totaling $9 trillion in monthly transaction volume on the Canton Network.
- Tharimmune, which established its digital asset treasury strategy in November 2025, also intends to invest in applications built on the Canton Network to accelerate institutional utility and adoption.
4 days ago
Tharimmune Closes $55 Million Direct Offering
THAR
New Projects/Investments
- Tharimmune, Inc. announced the closing of its previously announced underwritten registered direct offering, resulting in approximately $55 million in gross proceeds.
- The offering included the issuance of 1,800,000 shares of common stock at $2.92 per share and pre-funded warrants to purchase up to 17,000,000 shares of common stock at $2.9199 per pre-funded warrant.
- The company plans to use the proceeds for additional growth capital to expand its Canton-centric digital asset treasury strategy and for general corporate working capital.
Jan 22, 2026, 9:12 PM
Tharimmune, Inc. Announces Closing of Underwritten Registered Direct Offering
THAR
New Projects/Investments
- Tharimmune, Inc. announced the closing of an underwritten registered direct offering on January 22, 2026.
- The offering included the issuance of 1,800,000 shares of common stock at $2.92 per share and pre-funded warrants to purchase up to 17,000,000 shares of common stock at $2.9199 per pre-funded warrant.
- The company received approximately $55 million in gross proceeds from the offering.
- The proceeds will be used for the continued expansion and development of its Canton-centric digital asset treasury strategy and for general corporate purposes.
Jan 22, 2026, 9:12 PM
Tharimmune, Inc. announces pricing of $55 million registered offering
THAR
New Projects/Investments
- Tharimmune, Inc. announced the pricing of a $55 million underwritten registered offering on January 20, 2026.
- The offering includes the issuance of 1,800,000 shares of common stock at $2.92 per share and pre-funded warrants to purchase up to 17,000,000 shares of common stock at $2.9199 per pre-funded warrant.
- The offering is expected to close on or about January 21, 2026.
- The capital raised will provide additional growth capital for the expansion and development of the company's Canton-centric digital asset treasury strategy, as well as working capital for general corporate purposes.
Jan 20, 2026, 3:52 PM
Tharimmune Announces Pricing of $55 Million Registered Offering
THAR
New Projects/Investments
- Tharimmune, Inc. announced the pricing of a $55 million registered offering.
- The offering includes the issuance of 1,800,000 shares of common stock at $2.92 per share and pre-funded warrants to purchase up to 17,000,000 shares of common stock at $2.9199 per pre-funded warrant.
- The capital raised is intended for growth capital for the continued expansion and development of its Canton-centric digital asset treasury strategy, as well as working capital for general corporate purposes.
- The offering is expected to close on or about January 21, 2026.
Jan 20, 2026, 1:45 PM
Tharimmune Comments on DTCC's Treasury Tokenization Initiative
THAR
New Projects/Investments
- Tharimmune, Inc. (NASDAQ: THAR), the first publicly traded company to leverage Canton Coin, issued commentary on the Depository Trust & Clearing Corporation's (DTCC) partnership with Digital Asset Holdings to tokenize U.S. Treasury securities on the Canton Network.
- This collaboration is expected to move over $30 trillion in U.S. Treasury assets onchain, with the Canton Network currently handling $9 trillion in monthly transaction volume across more than 700,000 daily transactions.
- Tharimmune established a digital asset treasury strategy in November 2025 through a $545 million private placement to support the Canton Network's expansion and is pursuing roles as a Super Validator and application investor.
Dec 18, 2025, 1:15 PM
Fintool News
In-depth analysis and coverage of Tharimmune.
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more